STEAP1+ EVs in the plasma of healthymales and prostate cancer patients were characterized and evaluatedfor their diagnostic and prognostic significance. The findings suggest that liquid biopsy for the detectionof STEAP1+ EVs could be a noninvasive diagnostic strategyfor prostate cancer. The gene discussed is STEAP1; the disease is prostate cancer.